Soleno Therapeutics Inc (SLNO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $38.09
• Market Cap: $2.20B
• EPS: $-1.75
• 52-Week High: $90.32
• 52-Week Low: $36.67

Market Sentiment

Soleno Therapeutics Inc currently has a Bullish sentiment score of 0.35.

About Soleno Therapeutics Inc

Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, focused on developing novel therapies for rare diseases. The company utilizes its proprietary drug development platform to bring innovative treatments through clinical trials, effectively addressing significant unmet medical needs in this specialized market. Soleno's dedication to pioneering therapeutic solutions, combined with its strategic positioning in the rare disease sector...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Soleno Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SLNO pay dividends?

Soleno Therapeutics Inc (SLNO) does not currently pay a regular dividend.

What is SLNO's market cap?

Soleno Therapeutics Inc (SLNO) has a market capitalization of $2.20B with a current stock price of $38.09.